1. Home
  2. EQC vs NKTR Comparison

EQC vs NKTR Comparison

Compare EQC & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EQC
  • NKTR
  • Stock Information
  • Founded
  • EQC 1986
  • NKTR 1990
  • Country
  • EQC United States
  • NKTR United States
  • Employees
  • EQC N/A
  • NKTR N/A
  • Industry
  • EQC Real Estate Investment Trusts
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • EQC Real Estate
  • NKTR Health Care
  • Exchange
  • EQC Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • EQC 174.6M
  • NKTR 160.4M
  • IPO Year
  • EQC 1986
  • NKTR 1994
  • Fundamental
  • Price
  • EQC $1.61
  • NKTR $0.64
  • Analyst Decision
  • EQC
  • NKTR Strong Buy
  • Analyst Count
  • EQC 0
  • NKTR 6
  • Target Price
  • EQC N/A
  • NKTR $4.92
  • AVG Volume (30 Days)
  • EQC 1.6M
  • NKTR 2.8M
  • Earning Date
  • EQC 04-30-2025
  • NKTR 05-08-2025
  • Dividend Yield
  • EQC N/A
  • NKTR N/A
  • EPS Growth
  • EQC N/A
  • NKTR N/A
  • EPS
  • EQC 0.26
  • NKTR N/A
  • Revenue
  • EQC $57,570,000.00
  • NKTR $98,427,000.00
  • Revenue This Year
  • EQC N/A
  • NKTR N/A
  • Revenue Next Year
  • EQC N/A
  • NKTR N/A
  • P/E Ratio
  • EQC $6.10
  • NKTR N/A
  • Revenue Growth
  • EQC N/A
  • NKTR 9.21
  • 52 Week Low
  • EQC $1.40
  • NKTR $0.43
  • 52 Week High
  • EQC $21.00
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • EQC 43.27
  • NKTR 45.85
  • Support Level
  • EQC $1.58
  • NKTR $0.43
  • Resistance Level
  • EQC $1.63
  • NKTR $0.68
  • Average True Range (ATR)
  • EQC 0.02
  • NKTR 0.08
  • MACD
  • EQC 0.01
  • NKTR 0.01
  • Stochastic Oscillator
  • EQC 60.00
  • NKTR 72.41

About EQC Equity Commonwealth of Beneficial Interest

Equity Commonwealth is a real estate investment trust engaged in the acquisition, ownership, and operation of office buildings located throughout the United States. The vast majority of the company's real estate portfolio comprises office assets. These properties are fairly evenly dispersed between many of America's urban markets, notably Washington, Austin and Denver. Equity Commonwealth derives the vast majority of its income in the form of rental revenue from tenants occupying its offices.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: